Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Aliment Pharmacol Ther. 2013 Nov 17;39(2):10.1111/apt.12553. doi: 10.1111/apt.12553

Table 4.

Unanswered clinical questions regarding the role of vitamin D in inflammatory bowel diseases

  1. Does low serum vitamin D cause Crohn’s disease or ulcerative colitis, or is it a marker for other risk factors?

  2. Can supplementation with vitamin D in high-risk individuals prevent or delay the onset of Crohn’s disease or ulcerative colitis?

  3. Does vitamin D deficiency cause a more severe phenotype or increased inflammatory activity in Crohn’s disease, or is it merely a consequence of severity of disease? Is vitamin D status predictive of recurrence of Crohn’s disease post-operatively?

  4. What is the role of vitamin D Can supplementation with vitamin D in patients with IBD?

    • Induction of remission?

    • Maintenance of remission and prevention of relapse?

    • Prevention of post-operative recurrence?

  5. What is the optimal serum 25(OH)D level for its effect on inflammation in patients with IBD?

  6. What is the optimal dose and modality for treatment of vitamin D deficiency in IBD patients?

  7. Can vitamin D supplementation reduce risk of colorectal cancer in IBD?

HHS Vulnerability Disclosure